Who is the CEO of Global X S&P Biotech ETF?

Key leadership information for Global X S&P Biotech ETF, including the current CEO, is detailed in the company's official annual reports and proxy statements.

What industry does Global X S&P Biotech ETF belong to?

Global X S&P Biotech ETF operates in the Asset Management - Global industry within the Financial Services sector.

Where is Global X S&P Biotech ETF headquartered?

Global X S&P Biotech ETF is headquartered at AU.

What is the IPO date of Global X S&P Biotech ETF?

Global X S&P Biotech ETF went public on November 7, 2018.

How many employees does Global X S&P Biotech ETF have?

The total number of employees at Global X S&P Biotech ETF is disclosed periodically in the company's annual financial reports.

Global X S&P Biotech ETF

CURE.AX•ASX

Financial Services

Asset Management - Global

A$45.17

A$-0.08(-0.18%)

Global X S&P Biotech ETF (CURE.AX) Company Profile & Overview

Explore Global X S&P Biotech ETF’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Global X S&P Biotech ETF (CURE.AX) Company Profile & Overview

The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

SectorFinancial Services

IndustryAsset Management - Global

Contact Information

612 8311 3478

Company Facts

IPO DateNov 7, 2018

CountryAU

Actively Trading

Frequently Asked Questions

;